Bronchovascular Sleeve Resection

Updated: Mar 20, 2014
  • Author: Setu K Patolia, MD, MPH; Chief Editor: Zab Mosenifar, MD, FACP, FCCP  more...
  • Print


Lung cancer is the most common cancer in males and second most common cancer in females in the United States. Lung cancer is the number one cause of cancer-related deaths in males and females in the United States. Treatment options include surgery, chemotherapy, and radiotherapy, depending on the stage of the lung cancer.

After the introduction of pneumonectomy in 1895 by William Macewen, a number of options for surgical treatment of lung cancer have been introduced. Sleeve resection was first introduced in 1947 by Prince-Thomas. [1] Allison in 1959 reported first sleeve lobectomy with pulmonary artery construction. Sleeve lobectomy was considered inferior to pneumonectomy, but work by Ferugson et al and Deslauriers et al showed that sleeve lobectomy has better outcome and lower morbidity and mortality as compared to pneumonectomy. [2, 3]



See the list below:

  • Tumor invading/protruding main stem bronchus

  • As an alternative to pneumonectomy in patients with poor cardiopulmonary reserve

  • Endobronchial bronchogenic carcinoma

  • Carcinoid tumors and low-grade malignancy like bronchial gland carcinomas if complete resection can be obtained



See the list below:

  • Complete resection of tumor not achievable by bronchovascular sleeve resection

  • N2 disease (a relative contraindication)